Effects of twice-daily injections of premixed insulin analog on glycemic control in type 2 diabetic patients - Wikidata - awgldk - TriplyDB

Effects of twice-daily injections of premixed insulin analog on glycemic control in type 2 diabetic patients

Effects of twice-daily injections of premixed insulin analog on glycemic control in type 2 diabetic patients

http://www.wikidata.org/entity/Q34373342

about

Diabetes and gastric cancer: the potential links Obesity independently predicts responders to biphasic insulin 50/50 (Humalog Mix50 and Insuman Comb 50) following conversion from other insulin regimens: a retrospective cohort study Switching from Biphasic Human Insulin to Premix Insulin Analogs: A Review of the Evidence Regarding Quality of Life and Adherence to Medication in Type 2 Diabetes Mellitus.Use of 50/50 Premixed Insulin Analogs in Type 2 Diabetes: Systematic Review and Clinical Recommendations.Comparison of insulin lispro mix 25 with insulin lispro mix 50 as an insulin starter in Asian patients with type 2 diabetes: a phase 4, open-label, randomized trial (CLASSIFY study).

P2860

Q24602836-D867310B-B619-45A6-9950-AB52BE2C8102 Q34419149-2E7F445D-FAD1-429D-BF9C-799D2473E050 Q38980053-570C5B20-36E7-4020-98B6-CE94CD919661 Q50108204-962A731B-15AF-4C9B-80D3-B761438350D3 Q51284922-E5A3EC0A-EF85-48C0-8BEA-FDABBCB107A5

P2860

Effects of twice-daily injections of premixed insulin analog on glycemic control in type 2 diabetic patients

http://www.wikidata.org/entity/Q34373342

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Effects of twice-daily injecti ...... ol in type 2 diabetic patients

@ast

Effects of twice-daily injecti ...... ol in type 2 diabetic patients

@en

Effects of twice-daily injecti ...... ol in type 2 diabetic patients

@nl

type

label

Effects of twice-daily injecti ...... ol in type 2 diabetic patients

@ast

Effects of twice-daily injecti ...... ol in type 2 diabetic patients

@en

Effects of twice-daily injecti ...... ol in type 2 diabetic patients

@nl

prefLabel

Effects of twice-daily injecti ...... ol in type 2 diabetic patients

@ast

Effects of twice-daily injecti ...... ol in type 2 diabetic patients

@en

Effects of twice-daily injecti ...... ol in type 2 diabetic patients

@nl

P1433

Q34373342-285B149F-0856-439C-94AB-36360ACDEE5C

P1476

Q34373342-B1D7D026-9E29-46FA-9F6A-4BD1C4BABF02

P2093

Q34373342-25CFFE51-9603-4A29-8A71-D97D3AADF068

Q34373342-2F1DECF1-BC22-4636-8C6A-C15BBFDB3A82

Q34373342-339F8AFB-D6DE-4DB6-951C-9A95DFEC782C

Q34373342-450E08FB-1986-4ED5-A90F-C931CC59BE53

Q34373342-E0C5A451-BBA7-4054-A490-ECCFCC85140C

P2860

Q34373342-00590B65-C914-4EF8-862C-B2F79B87A1BB

Q34373342-1D2175E3-4E20-437E-8493-D4A787DAD15C

Q34373342-29319326-6295-4C07-A372-871C4B58BDFA

Q34373342-3E9F957C-2484-444F-80D2-317C65ABDAB7

Q34373342-3FE50547-F9AE-495A-9F2A-83D78E7FFF47

Q34373342-7B3A1312-B275-45D7-B978-3E5B096BFDA7

Q34373342-8B7E3298-0272-4592-8EF5-D4FA9B640133

Q34373342-8D00FA85-D39C-4893-B67C-A4D0F4C1A195

Q34373342-D0E5B045-805F-427D-B14F-E7F567F078FA

Q34373342-FC146A59-9FA1-4ED9-85FC-6F66FDB8567E

P304

Q34373342-04510AD2-1D0A-45B9-AE66-FBE2B55BA2DA

P31

Q34373342-9E6E5910-5579-4E22-870D-83F887214D09

P356

Q34373342-2D5F94CC-9B88-446F-981D-44B78279FB1D

P433

Q34373342-1499B985-17C7-4184-9DE1-43505DD7CEF8

P478

Q34373342-ABB3178B-5B48-4E18-84E6-A24162BA2B88

P577

Q34373342-D53B70D2-CA1B-44F7-A0BB-6D3D270D5D0B

P5875

Q34373342-0F2FDE5F-183E-4AD2-9170-76253D9B85E0

P698

Q34373342-6265FF11-CD3B-476F-B215-CCC829D643D0

P921

Q34373342-F59D16A0-83A0-4D37-BE58-37522C8FB582

P932

Q34373342-EA28AC5C-E471-40AC-9E99-536AB66CBB61

P356

YMJ.2010.51.6.845

P1433

Yonsei Medical Journal

P1476

Effects of twice-daily injecti ...... ol in type 2 diabetic patients

@en

P2093

Hiroaki Shimizu

http://www.w3.org/2001/XMLSchema#string

Kikuo Kasai

http://www.w3.org/2001/XMLSchema#string

Mihoko Matsumura

http://www.w3.org/2001/XMLSchema#string

Nozomi Domeki

http://www.w3.org/2001/XMLSchema#string

Tsuyoshi Monden

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan.

Humalog Mix50 before carbohydrate-rich meals in type 2 diabetes mellitus.

Metabolic control in patients with type 2 diabetes using Humalog Mix50 injected three times daily: crossover comparison with human insulin 30/70.

Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes.

Comparison of twice-daily injections of biphasic insulin lispro and basal-bolus therapy: glycaemic control and quality-of-life of insulin-naïve type 2 diabetic patients.

A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.

Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.

P304

845-849

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3349/YMJ.2010.51.6.845

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46581141

http://www.w3.org/2001/XMLSchema#string

P698

20879049

http://www.w3.org/2001/XMLSchema#string

P921

P932

2995960

http://www.w3.org/2001/XMLSchema#string